Clinical Trial Update: Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for stereoTactic Ablative Adaptive Radiotherapy treatments in localized prostate cancer (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Prostate Adenocarcinoma | Phase 1, Phase 2 | Status: UNKNOWN